Abstract:Sang Mi Park, 1, 2 Da Yeon Kim, 3 Kyeong Hyeon Lee, 1 Yong-Il Shin, 1, 4 Sang-Cheol Han, 5 Sang-Mo Kwon 1, 2 1 Department of Physiology, Laboratory of Vascular Medicine and Stem Cell Biology, School of Medicine, Pusan National University, Yangsan, Republic of Korea; 2 BK21 GRAND Convergence Medical Science Education Research Center, Pusan National University, Yangsan, South Korea; 3 Genetic & Epigenetic Toxicology Research Group, Korea Institute of Toxicology (KIT), Daejeon, Republic of Korea; 4 Department of Rehabilitation Medicine, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea; 5 CEN Co., Ltd. Nanoconvergence Center, Muan-ro, Miryang, 761, Republic of Korea Correspondence: Sang-Mo Kwon, Department of Physiology, Laboratory of Vascular Medicine and Stem Cell Biology, School of Medicine, Pusan National University, Yangsan, Republic of Korea, Tel +82-51-510-8072, Fax +82-51-510-8076, Email Purpose: 5-fluorouracil (5-FU) is a first-line chemotherapeutic agent used to treat colorectal cancer (CRC). However, 5-FU induces drug resistance and activation of cancer stem cells (CSCs). In the present study, we designed a novel biocompatible nanomedicine system with high efficacy and biocompatibility by synthesizing mesoporous silica nanoparticle (MSN)-structured ZnO and gold ions. Oleuropein (OLP) is a phenolic compound derived from olive leaves that exerts anti-cancer effects. Therefore, we synthesized OLP-loaded ZnO/Au MSNs (ZnO/Au/OLP MSNs) and examined their anti-cancer effects on 5-FU-resistant CRC cells. Methods: ZnO/Au MSNs were synthesized and functionalized, and their physical and chemical compositions were characterized using UV-visible spectroscopy, dynamic light scattering, and transmission electron microscopy (TEM). Their effects were assessed in terms of cellular proliferation capacity, migration and invasion ability, colony-forming ability, spheroid-forming ability, reactive oxygen species (ROS) production, and mitochondrial membrane depolarization. Results: ZnO/Au MSNs were mostly composed of various ions containing ZnO and gold ions, had a spheroid phenotype, and exhibited no cytotoxicity. ZnO/Au/OLP MSNs reduced cell viability and CSC formation and induced apoptosis of 5-FU-resistant CRC cells via necrosis via ROS accumulation and DNA fragmentation. Conclusion: ZnO/Au/OLP MSNs exhibited anti-cancer activity by upregulating necrosis. These results revealed that ZnO/Au/OLP MSNs are a novel drug delivery system for 5-FU CRC therapy. Keywords: gold nanoparticles, drug resistance, MSNs, AuNPs, colorectal cancer cell, oleuropein Colorectal cancer (CRC) is the third most common cause of cancer-related mortality worldwide, with more than 1.85 million cases and 850,000 deaths annually. 1 Chemotherapy is commonly used to treat patients with colorectal cancer. However, conventional chemotherapeutic agents have many side effects due to their toxicity to normal cells. 2 5-Fluorouracil (5-FU) is a first-line treatment for CRC. However, its use has many limitations owing to the various side effects and drug resistance of cancer cells. The most common adverse effects include leukopenia, diarrhea, stomatitis, nausea, vomiting, and alopecia. 3 Resistance to chemotherapy is a major hurdle in CRC treatment, often mediated through various cellular mechanisms. These include the overexpression of drug efflux pumps, alterations in drug targets, enhanced DNA repair mechanisms, and evasion of apoptosis. Key biomarkers linked to chemoresistance in CRC include the overexpression of the ABC transporters, mutations in KRAS and BRAF genes, and alterations in the TP53 and APC genes. These biomarkers are crucial in understanding the resistance pathways and targeting them therapeutically. Therefore, novel therapeutic systems targeting cancer cells with fewer side effects are required. Oleuropein (OLP), the main polyphenol in olive leaf extract, has shown anti-cancer effects against many types of cancer, including breast, 4 liver, 5 colorectal, 6–8 thyroid, 9 skin, 10 and lung cancers. 11 Accumulating evidence has shown that OLP reduces drug resistance in cancer cells. Upon treatment with oleuropein, the expression levels of p21, p53, and TNFRSF10B increase, whereas those of Bcl-2 and Mcl1 decrease in cisplatin-resistant ovarian cancers. In addition, OLP effectively reverses trastuzumab resistance in Tzb-resistant breast cancer cells via downregulation of HER2 expression. 12–14 In the context of CRC, previous studies have highlighted OLP's potential in targeting pathways implicated i -Abstract Truncated-

Oleuropein-Rich Leaf Extract as a Broad Inhibitor of Tumour and Macrophage iNOS in an Apc Mutant Rat Model

Changes in Faecal Microbiota Profile and Plasma Biomarkers following the Administration of an Antioxidant Oleuropein-Rich Leaf Extract in a Rat Model Mimicking Colorectal Cancer

Gene Expression Alterations Associated with Oleuropein-Induced Antiproliferative Effects and S-Phase Cell Cycle Arrest in Triple-Negative Breast Cancer Cells

Anti-proliferation and migration effects of oleuropein on human A549 lung carcinoma cells

Redox State Modulatory Activity and Cytotoxicity of Olea europaea L. (Oleaceae) Leaves Extract Enriched in Polyphenols Using Macroporous Resin

Abstract 7298: A nutraceutical supplement derived from olive oil byproducts exhibits potential cancer preventive properties in preclinical studies and increases vitamin D levels

Olive leaf (Olea europaea L. folium) extract influences liver microsomal detoxifying enzymes in rats orally exposed to 2-amino-l-methyI-6-phenyI-imidazo pyridine (PhIP)

Oleuropein: a viable therapeutic option for malaria and cancer

Glycolysis, a new mechanism of oleuropein against liver tumor

Paradigm Shift in Gastric Cancer Prevention: Harnessing the Potential of Aristolochia olivieri Extract

Olive Leaves as a Source of Anticancer Compounds: In Vitro Evidence and Mechanisms

Polyyne-Enriched Extract from Oplopanax Elatus Significantly Ameliorates the Progression of Colon Carcinogenesis in ApcMin/+ Mice

In vitro anticancer and antifungal properties of the essential oil from the leaves of Lippia origanoides kunth

IL-17A Drives Oxidative Stress and Cell Growth in A549 Lung Epithelial Cells: Potential Protective Action of Oleuropein

Dietary Supplementation of Olive Mill Waste Water Polyphenols in Rabbits: Evaluation of the Potential Effects on Hepatic Apoptosis, Inflammation and Metabolism through RT-qPCR Approach

Evidence to Support the Anti-Cancer Effect of Olive Leaf Extract and Future Directions

Anti-Tumor Efficacy of Oleuropein-Loaded ZnO/Au Mesoporous Silica Nanoparticle in 5-FU-Resistant Colorectal Cancer Cells

Dietary oleuropein inhibits tumor angiogenesis and lymphangiogenesis in the B16F10 melanoma allograft model: a mechanism for the suppression of high-fat diet-induced solid tumor growth and lymph node metastasis

Targeting OLFML3 in Colorectal Cancer Suppresses Tumor Growth and Angiogenesis, and Increases the Efficacy of Anti-PD1 Based Immunotherapy

The Role of Nrf2 and Apoptotic Signaling Pathways in Oroxylin A-Mediated Responses in Hct-116 Colorectal Adenocarcinoma Cells and Xenograft Tumors

Oleuropein inhibits the proliferation and invasion of glioma cells via suppression of the AKT signaling pathway.